a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology
Industry Biotechnology
A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.
Ticker / NAME | Correlation To OCUL | 1D Price Change % | ||
---|---|---|---|---|
OCUL | 100% | N/A | ||
EYPT - OCUL | 49% Loosely correlated | -3.15% | ||
RCUS - OCUL | 43% Loosely correlated | -2.03% | ||
PLRX - OCUL | 43% Loosely correlated | -0.36% | ||
BEAM - OCUL | 40% Loosely correlated | -1.57% | ||
ALDX - OCUL | 39% Loosely correlated | -7.26% | ||
More |
Ticker / NAME | Correlation To OCUL | 1D Price Change % |
---|---|---|
OCUL | 100% | N/A |
hybrid power theme (2 stocks) | 98% Closely correlated | +3.10% |
eye theme (8 stocks) | 44% Loosely correlated | -2.41% |
therapy theme (23 stocks) | 39% Loosely correlated | -3.41% |
pharmaceuticals theme (159 stocks) | 38% Loosely correlated | -1.94% |